Maintenance Treatment Using Abatacept with Dose Reduction after Achievement of Low Disease Activity in Patients with Rheumatoid Arthritis (MATADOR) - a Prospective, Multicentered, Single Arm Clinical Trial

被引：0

作者：

Yasuda, Shinsuke ^{[1
]}

Ohmura, Kazumasa ^{[1
]}

Kanazawa, Hiroshi ^{[2
]}

Kurita, Takashi ^{[1
]}

Kon, Yujiro ^{[3
]}

Ishii, Tomonori ^{[4
]}

Jodo, Satoshi ^{[5
]}

Tanimura, Kazuhide ^{[6
]}

Minami, Michio ^{[7
]}

Izumiyama, Tomomasa ^{[8
]}

Matsumoto, Takumi ^{[9
]}

Amasaki, Yoshiharu ^{[10
]}

Suzuki, Yoko ^{[11
]}

Kasahara, Hideki ^{[12
]}

Yamauchi, Naofumi ^{[13
]}

Tsutsumi, Akito ^{[3
]}

Takemori, Hiromitsu ^{[2
]}

Koike, Takao ^{[14
]}

Atsumi, Tatsuya ^{[1
]}

机构：

[1] Hokkaido Univ, Grad Sch Med, Div Rheumatol Endocrinol & Nephrol, Sapporo, Hokkaido, Japan

[2] Aomori Prefectural Cent Hosp, Dept Rheumatol, Aomori, Japan

[3] Takikawa Municipal Hosp, Dept Internal Med, Takikawa, Hokkaido, Japan

[4] Tohoku Univ, Grad Sch Med, Dept Hematol & Rheumatol, Sendai, Miyagi, Japan

[5] Tomakomai City Hosp, Dept Internal Med, Tomakomai, Japan

[6] Hokkaido Med Ctr Rheumat Dis, Sapporo, Hokkaido, Japan

[7] Hokkaido Orthopaed Mem Hosp, Dept Rheumatol & Orthopaed Surg, Sapporo, Hokkaido, Japan

[8] Higashisendai Rheumat Dis Clin, Sendai, Miyagi, Japan

[9] Kin Ikyo Chuo Hosp, Div Rheumatol, Sapporo, Hokkaido, Japan

[10] Tonan Hosp, Ctr Rheumat Dis, Sapporo, Hokkaido, Japan

[11] Izumi Himawari Clin, Sendai, Miyagi, Japan

[12] NTT Sapporo Med Ctr, Rheumatol, Sapporo, Hokkaido, Japan

[13] Sapporo Kiyota Hosp, Sapporo, Hokkaido, Japan

[14] NTT Sapporo Med Ctr, Sapporo, Hokkaido, Japan

来源：

ARTHRITIS & RHEUMATOLOGY | 2016年 / 68卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1601

引用

页数：2

共 50 条

[1] Maintenance treatment using abatacept with dose reduction after achievement of low disease activity in patients with rheumatoid arthritis (MATADOR) - A prospective, multicenter, single arm pilot clinical trial
Yasuda, Shinsuke
Ohmura, Kazumasa
Kanazawa, Hiroshi
Kurita, Takashi
Kon, Yujiro
Ishii, Tomonori
Fujieda, Yuichiro
Jodo, Satoshi
Tanimura, Kazuhide
Minami, Michio
Izumiyama, Tomomasa
Matsumoto, Takumi
Amasaki, Yoshiharu
Suzuki, Yoko
Kasahara, Hideki
Yamauchi, Naofumi
Kato, Masaru
Kamishima, Tamotsu
Tsutsumi, Akito
Takemori, Hiromitsu
Koike, Takao
Atsumi, Tatsuya
MODERN RHEUMATOLOGY, 2017, 27 (06) : 930 - 937
[2] LOW DOSE OF RITUXIMAB IS EFFECTIVE FOR MAINTENANCE OF CLINICAL REMISSION OR LOW DISEASE ACTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS
Argoustidis, N.
Flouri, I.
Adamichou, C.
Kabouraki, E.
Eskitzis, A.
Kyfonidou, P.
Papalopoulos, I.
Fanouriakis, A.
Repa, A.
Kougkas, N.
Bertsias, G.
Sidiropoulos, P.
ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 577 - 577
[3] Dose reduction of tocilizumab in rheumatoid arthritis patients with low disease activity
van Herwaarden, N.
Herfkens-Hol, S.
van der Maas, A.
van den Bemt, B. J. F.
van Vollenhoven, R. F.
Bijlsma, J. W. J.
den Broeder, A. A.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (03) : 390 - 394
[4] TRAJECTORIES OF DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS PATIENTS AFTER ABATACEPT INITIATION AND THEIR ASSOCIATION WITH CLINICAL CHARACTERISTICS
Courvoisier, D. S.
Gottenberg, J. -E.
Hernandez, M. V.
Iannone, F.
Lie, E.
Canhao, H.
Pavelka, K.
Hetland, M.
Turesson, C.
Mariette, X.
Choquette, D.
Finckh, A.
ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 451 - 452
[5] Dose Reduction Of Tocilizumab In Rheumatoid Arthritis Patients With Low Disease Activity Is Feasible
van Herwaarden, Noortje
Herfkens-Hol, Susan
van der Maas, Aatke
van Den Bemt, Bart J. F.
van Vollenhoven, Ronald F.
Bijlsma, Johannes W. J.
den Broeder, Alfons A.
ARTHRITIS AND RHEUMATISM, 2013, 65 : S992 - S992
[6] DOSE REDUCTION OF TOCILIZUMAB IN RHEUMATOID ARTHRITIS PATIENTS WITH LOW DISEASE ACTIVITY: A PILOT STUDY
van Herwaarden, N.
Herfkens-Hol, S.
van der Maas, A.
van den Bemt, B.
van Vollenhoven, R.
Bijlsma, J.
den Broeder, A.
ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 886 - 886
[7] Maintenance of remission following 2 years of standard treatment then dose reduction with abatacept in patients with early rheumatoid arthritis and poor prognosis
Westhovens, Rene
Robles, Manuel
Ximenes, Antonio Carlos
Wollenhaupt, Jurgen
Durez, Patrick
Gomez-Reino, Juan
Grassi, Walter
Haraoui, Boulos
Shergy, William
Park, Sung-Hwan
Genant, Harry
Peterfy, Charles
Becker, Jean-Claude
Murthy, Bindu
ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (03) : 564 - 568
[8] Dose reduction of rituximab in clinical practice: a retrospective cohort study of rheumatoid arthritis patients in low disease activity on rituximab
Wientjes, M. H. M.
van Huissteden, J.
van Herwaarden, N.
Verhoef, L. M.
den Broeder, A. A.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2024, 42 (11) : 2215 - 2220
[9] Adalimumab Dose Reduction Using Therapeutic Drug Monitoring to Manage Low Disease Activity in Rheumatoid Arthritis: A Single-Blind, Non-Inferiority, Randomized Clinical Trial
Atiqi, Sadaf
Wientjes, Maike
Leeuw, Maureen
Boekel, Laura
Hooijberg, Femke
Loeff, Floris
Krieckaert, Charlotte
De Vries, Annick
Nurmohamed, Michael
Rispens, Theo
Boers, Maarten
van den Bemt, Bart
den Broeder, Alfons
Wolbink, Gertjan
ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 4564 - 4566
[10] PREDICTIVE FACTORS FOR ACHIEVEMENT OF LOW DISEASE ACTIVITY AT 52 WEEKS ARE DIFFERENT BETWEEN YOUNG AND ELDERLY RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ABATACEPT
Takahashi, N.
Kojima, T.
Asai, S.
Ishiguro, N.
ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 326 - 327

← 1 2 3 4 5 →